News

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...
The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.
Central District Health (CDH) will continue to provide COVID-19 vaccines to residents in Ada, Boise, Elmore, and Valley ...
Moderna (MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...
In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...